Summary & Overview
HCPCS S9537: Home Hematopoietic Hormone Injection Therapy, Administrative Services
HCPCS Level II code S9537 designates per-diem administrative and professional pharmacy services for home-based hematopoietic hormone injection therapy, such as erythropoietin or colony-stimulating factors. The code captures care coordination, supplies, and equipment needed to support home injection regimens while the actual drug products and nursing visits are billed separately. Nationally, this code matters for payers and providers coordinating complex outpatient and home-based supportive care for patients requiring hematopoietic growth factors.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and service setting, guidance on how the code is used alongside separate drug and nursing line items, and discussion of common billing considerations. The publication also summarizes benchmarks and policy updates relevant to per-diem home therapy administrative codes, and outlines operational implications for pharmacy, care coordination, and home infusion programs.
Data not available in the input for specific associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code S9537 describes home therapy for hematopoietic hormone injection therapy (for example, erythropoietin, G-CSF, GM-CSF). The code covers administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment provided on a per diem basis. Drugs and nursing visits associated with the therapy are coded separately.
Service type: Home infusion and therapy administrative services
Typical site of service: Patient's home (home health/home infusion setting)
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with chronic kidney disease stage 4 and symptomatic anemia is enrolled in a home infusion program for hematopoietic growth factor management. The physician prescribes epoetin alfa for weekly subcutaneous administration to maintain hemoglobin levels and reduce transfusion risk. A specialty pharmacy coordinates drug procurement, pre-filled syringes are delivered to the patient’s home, and a licensed nurse performs an initial home visit for education, safe injection technique review, and assessment of vascular access site. Ongoing per diem administrative services include prior authorization support, scheduling of nursing visits when needed, medication storage counseling, documentation of hemoglobin response, adverse event surveillance, and care coordination with the nephrology team.
Typical clinical workflow:
-
The prescribing clinician documents indication and dose in the medical record and places the specialty pharmacy order.
-
The specialty pharmacy obtains prior authorization, dispenses
erythropoietinproduct (drug billed separately), and schedules home nursing visits if required. -
On the first home visit a nurse provides education, documents baseline vitals and injection site assessment, and demonstrates injection technique.
-
The payer-billed per diem administrative service
S9537covers professional pharmacy services, coordination, supplies, and administrative tasks; the actual drug and nursing visits are billed separately under their respective HCPCS/CPT codes. -
Follow-up lab monitoring (hemoglobin/hematocrit) is coordinated; dose adjustments are communicated to the pharmacy and clinician. Adverse events (hypertension, thrombotic symptoms) are reported and managed per provider orders.